This company has shut down. Scorpion Therapeutics is no longer operating — its last tracked round was a Series C in 2024.
Explore the Startup GraveyardScorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Scorpion Therapeutics has raised $150.0M in total funding. The most recent round was Series C. The last funding was announced in July 2024.
Scorpion Therapeutics's investors include Lightspeed Venture Partners, Janus Henderson Investors, Wellington Management, OrbiMed, Abingworth.
Scorpion Therapeutics is headquartered in Boston, United States.
Scorpion Therapeutics is a clinical-stage oncology company that specializes in precision medicine for cancer patients.
Scorpion Therapeutics is at the Series C stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Scorpion Therapeutics — Funding & Investors." VCBacked, July 16, 2024, https://www.vcbacked.co/company/scorpion-therapeutics. Accessed September 30, 2026.
VCBacked. (2024). Scorpion Therapeutics — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/scorpion-therapeutics
{{cite web |title=Scorpion Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/scorpion-therapeutics |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated